Open AccessClinical perspectives of cefditoren pivoxil - new oral third generation cephalosporin
Author(s) -
Vladimir B. Beloborodov
Publication year - 2016
Publication title -
èpidemiologiâ i infekcionnye bolezni
Language(s) - English
Resource type - Journals
eISSN - 2411-3026
pISSN - 1560-9529
DOI - 10.17816/eid40921
Subject(s) - cephalosporin , antibiotics , penicillin , medicine , cephalosporin antibiotic , cephalosporin c , flora (microbiology) , microbiology and biotechnology , biology , bacteria , genetics
The resistance of community flora is growing slowly. Nevertheless, clinical value of actual resistance of the respiratory, skin, soft tissue and urological pathogens is increasing in relation to macrolides, penicillin, quinolones that demands on the introduction of new antibiotics. Cefditoren pivoxil appeared rather recently in the Russian Federation. Results of microbiological and clinical comparative trials showed its high efficiency and safety as an alternative to the applied antibiotics.